References
- Shiomou K, Galanakis E, Tzoufi M, Tsaousi C, Papadopoulou Z. Transient lupus anticoagulant and prolonged activated partial thromboplastin time secondary to Epstein-Barr virus infection. Scand J Infect Dis 2002; 34: 67–9.
- Brandt J, Triplett D, Alving B, Scharrer I. Criteria for the diagnosis of lupus anticoagulant: an update. Thromb Haemost 1995; 74: 1185–90.
- Uthman IW, Gharavi A. Viral infections and antiphospholipid antibodies. Semin Arthritis Rheum 2002; 31: 256–3.
- Dalekos G, Zachou K, Liaskos C. The antiphospholipid syndrome and infection. Curr Rheumatol Rep 2001; 3: 27785.
- Male C, Lechner K, Eichinger S, Kyrle PA, Kapiotis S, Wank H. Clinical significance of lupus anticoagulants in children. J Pediatr 1999; 134: 199–205.
- Hoffman R, Benz EJ, Shattil SJ, Furil B, Cohen HJ, Silberstein LE, eds. Inhibitors of blood coagulation. In: Hematology. Basic principles and practice, 2nd edn. Edinburgh: Churchill Livingstone; 1995. p. 1746–55.
- Doyle G, Simmons M, Granke K. Axillary vein thrombosis during pregnancy in association with a lupus anticoagulant. W V Med J 1998; 94: 87–9.